FDA Inspection 679919 — Janssen Biologics B.V.
The FDA completed an inspection of Janssen Biologics B.V. on Jul 6, 2010 in Leiden. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 6, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Leiden (Netherlands)